Roxithromycin

Price	$1
Package	1kg

Product Details

Product Name: Roxithromycin	CAS No.: 80214-83-1
Min. Order: 1g	Purity: 99%
Supply Ability: 100KG	Release date: 2019/07/06
Product:: AD68

Roxithromycin Basic information

Pharmacological effects Indications Chemical properties Uses Production method

Product Name:	Roxithromycin
Synonyms:	ROXITHROMYCIN;ERYTHROMYCIN 9-(-O-[2-METHOXYETHOXY]METHYLOXIME);ERYTHROMYCIN, 9-[O-[(2-METHOXYETHOXY)METHYL]OXIME], (9E)-;Roxithromycin CP2000;Roxithromycin EP;RoxithromycinEp/Bp/CpC41H76N2O15;RoxithromycinC41H76N2O15;(9E)-9-[O-[(2-Methoxyethoxy)methyl]oxime] Erythromycin
CAS:	80214-83-1
MF:	C41H76N2O15
MW:	837.05
EINECS:	1308068-626-2
Product Categories:	Antibiotic Explorer;Intermediates & Fine Chemicals;Pharmaceuticals;veterinary medicine,soluble powder;Peptide Synthesis/Antibiotics;Chiral Reagents
Mol File:	80214-83-1.mol

Roxithromycin Chemical Properties

Melting point	111-118?C
alpha	D25 -77.5 ±2° (c = 0.45 in chloroform)
Fp	>110°(230°F)
storage temp.	2-8°C
solubility	chloroform: soluble10mg/mL
pka	pKa 9.27±0.01(H2O t = 25.0 I = 0.15 (KCl)) (Uncertain)
Water Solubility	Soluble in water to 18µg/ml
Merck	14,8276

Safety Information

Hazard Codes	Xn
Risk Statements	22
Safety Statements	26-24/25
RTECS	KF4990000
HS Code	29415000

MSDS Information

Roxithromycin Usage And Synthesis

Pharmacological effects	Roxithromycin is a semi-synthetic 14-membered ring macrolide antibiotic. It has similar mechanism of action as erythromycin with its antibacterial effect in vivo being 1-4 times stronger than erythromycin. Its effect against Gram-positive bacteria is slightly worse than erythromycin; the effect against Legionella pneumophila is somehow stronger than erythromycin; for Chlamydia pneumoniae, Mycoplasma pneumoniae and Ureaplasma urealyticum, it has similar or slightly stronger antimicrobial effect compared with erythromycin. This product can penetrate through the bacterial cell membrane, having reversible binding to bacterial ribosomes 50S subunit at close to the donor ("P" position), blocking the transfer of ribonucleic acid binding to the "P" position as well as blocking the transfer of the peptide chain from the acceptor position ("A" position) to "P" position, thus leading to the inhibition of bacterial protein synthesis and playing an antibacterial effect. It is characterized by faster access to macrophages, alveolar cells and neutrophils. In vitro studies have shown that roxithromycin has broad antibacterial spectrum with similar effect as erythromycin against a variety of Streptococcus (including A, B, C-type streptococcus and Streptococcus pneumoniae, but except G-type and enterococci), Streptococcus pneumoniae, Staphylococcus aureus, Staphylococcus aureus (except MRSA), Staphylococcus epidermidis, Legionella pneumophila, Haemophilus ducreyi, Chlamydia trachomatis, Mycoplasma pneumoniae and oral or vaginal anaerobic bacteria. Neisseria catarrhalis is highly sensitive to roxithromycin. It also has inhibitory effects on Campylobacter, Bordetella pertussis, Haemophilus influenzae, Mycobacterium tuberculosis and Diphtheria bacilli but has no antibacterial activity against other gram-negative bacteria. The in vivo antibacterial activity of this product was significantly stronger than that of erythromycin. It also has significant effect against chlamydia, mycoplasma, ureaplasma urealyticum, Treponema pallidum and Legionella infection. It also has relatively weak effect on the helicobacter, Neisseria gonorrhoeae, meningococcal and Bordetella pertussis. Some bacteria have cross-resistance to erythromycin and this product.
Indications	This product is applicable to the purulent Streptococcus caused pharyngitis and tonsillitis, susceptible bacteria-caused sinusitis, otitis media, acute bronchitis, acute exacerbation of chronic bronchitis, Mycoplasma pneumoniae or Chlamydia pneumoniae caused pneumonia; Chlamydia trachomatis caused urinary reproductive system infections (urethritis and cervicitis); sensitive bacteria caused infection of skin soft tissue and other parts of the body; it can also used for non-specific and gonococcal genital infection, Legionella caused infection and Pediatric Infections. Roxithromycin is characterized by acid resistance and excellent oral absorption with T1/2 being 12 to 14 hours which is 6 times higher than erythromycin. It has wide distribution in the body and is able to reach high concentration in both the upper and lower respiratory tract, reproductive tract and skin and maintain for a long time. Most of the metabolism occurs in vivo. Roxithromycin clinical evaluation: the curing rate of chlamydia urethritis, cervicitis clinical and bacteriological was 93% to 97%; the efficacy against genital infection is similar to doxycycline; the cure rate for skin infection is 90% or more; the effectiveness for the treatment of respiratory infections is 83% and 50% while the effectiveness for the treatment of pneumonia and dental infections are 79% and 85%.
Chemical properties	It appears as White crystalline powder, odorless, bitter taste. It is easily soluble in ethanol or acetone, more easily soluble in methanol or ether but almost do not dissolve in water. [Α] D23-77.5 ° ± 2 ° (c = 0.45, chloroform).
Uses	1. It belongs to macrolide antibiotics, being a kind of erythromycin derivative with the antibacterial spectrum being similar as erythromycin but having a 6 times stronger effect on erythromycin with high bioavailability. It is used for the treatment of respiratory tract infection, such as pneumonia, acute bronchitis, acute infection of chronic bronchitis, atypical pneumonia, and genitourinary system infection, skin and soft tissue infections, having good therapeutic effect and tolerance with smaller adverse reactions than erythromycin. 2. As the new generation of macrolide antibiotics; 3. The product belongs to a new generation of macrolide antibiotics, mainly used for Gram-positive bacteria, anaerobes, chlamydia and mycoplasma. Its antibacterial activity in vitro is similar as erythromycin with its in vivo effect being 1-4 times stronger than erythromycin. Pharmacological effects and indications 1, it has strong bactericidal effect on Gram-negative bacteria and some Gram-negative bacteria (meningococcus, Neisseria gonorrhoeae, influenza bacilli, pertussis, Brucella) and spirochetes, Mycoplasma pneumoniae and Rickettsia. Legionella is sensitive to it; its effect against mycoplasma and chlamydia is further enhanced. 4. 2, antibacterial mechanism: it can bind to the bacterial ribosome 50S subunit, through blocking the peptidyl transfer and MRNA displacement, further inhibiting the protein synthesis. 3, this product has excellent oral absorption and quick efficacy with stronger bioavailability and plasma concentrations than erythromycin. According to reports, oral administration of 150 mg can lead to a peak plasma concentration of up to 6.6~7.9 ug/ml while the value for erythromycin under the same conditions is only 0.2~0.4ug/ml; roxithromycin is mainly distributed in body fluids and tissues, with high and durable tissue concentration and cell concentration. Moreover, it has a half-life of up to 12 h while the value for erythromycin is only 1.5~2.0h. 4, in clinical medicine, it is the first-choice drug for the treatment of drug-resistance Staphylococcus aureus and hemolytic streptococcus. In veterinary clinical practice, it is used for the treatment of penicillin-resistant staphylococcus aureus caused severe infection, pneumonia, uterine inflammation and poultry chronic respiratory disease. 5, the goods are mainly used for the treatment of livestock and poultry chronic respiratory disease with good efficacy in the treatment of livestock and poultry staphylococcus and streptococcal disease, chlamydia, spirocheal disease (swine dysentery), infectious pleurisy and rhinitis. 6, indications: avian neck swelling, local heat, pain, difficulty breathing, mouth and nose flow white foam, mucous membranes and skin cyanosis and other symptoms.
Production method	Take erythromycin as raw materials for reaction with hydroxylamine hydrochloride in triethylamine and methanol, generating oxime, followed by reaction with methoxy ethoxymethyl chloride in acetone to derive roxithromycin.
Chemical Properties	White Solid
Uses	anesthetic (local)
Uses	Roxithromycin was one of the new generation erythromycins introduced in the 1980s. Improved acid stability was achieved by converting the 9-keto group to the more stable oxime and alkylation of the oxime to provide the methoxyethoxymethyl ether oxime. In vivo, roxithromycin exhibits higher tissue levels and a longer half-life while being slightly less potent than erythromycin in vitro.
Uses	Semisynthetic erythromycin derivative. Antibacterial
Brand name	Rulide (Hoechst-Roussel).

Company Profile Introduction

Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals. Mainly deals in the sales of: Pharmaceutical intermediates OLED intermediates： Pharmaceutical intermediates; OLED intermediates;

Recommended supplier

Product name	Price		Suppliers	Update time
Roxithromycin	$0.00/1kg	VIP1Y	Shaanxi TNJONE Pharmaceutical Co., Ltd	2024-04-07
Roxithromycin	$0.00/1kg	VIP4Y	Hebei Yanxi Chemical Co., Ltd.	2023-09-20
Roxithromycin	$20.00/1kg	VIP2Y	Hebei Duling International Trade Co. LTD	2023-02-21
Roxithromycin	$0.00/25KG	VIP4Y	Hebei Mojin Biotechnology Co., Ltd	2022-06-29
Roxithromycin	$36.00/1KG		Shijiazhuang tongyang Import and Export Co., LTD	2021-08-12
Roxithromycin	$70.00/1KG	VIP3Y	Hebei Lingding Biotechnology Co., Ltd.	2021-07-20
Roxithromycin	$15.00/1KG		Zhuozhou Wenxi import and Export Co., Ltd	2021-07-10
Spectinomycin	$15.00/1KG	VIP3Y	Hebei Guanlang Biotechnology Co,.LTD	2021-06-24
Roxithromycin USP/EP/BP	$1.10/1g	VIP3Y	Dideu Industries Group Limited	2021-06-22
Roxithromycin	$100.00/1KG		Baoji Guokang Healthchem co.,ltd	2021-06-08

Product Details

Company Profile Introduction

You may like

Recommended supplier

career henan chemical co